Triglycerides and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort: The Suita study

被引:25
|
作者
Okamura, Tomonori [1 ]
Kokubo, Yoshihiro [1 ]
Watanabe, Makoto [1 ]
Higashiyama, Aya [1 ]
Ono, Yuu [1 ]
Miyamoto, Yoshihiro [2 ]
Yoshimasa, Yasunao [2 ]
Okayama, Akira [3 ]
机构
[1] Natl Cardiovasc Ctr, Dept Prevent Cardiol, Osaka 5658565, Japan
[2] Natl Cardiovasc Ctr, Dept Atherosclerosis & Diabet, Osaka 5658565, Japan
[3] Japan Anti TB Assoc, Inst Hlth Promot & Hlth Care 1, Tokyo, Japan
关键词
Triglycerides; Myocardial infarction; Stroke; Cohort studies; Lipids and lipoprotein; CORONARY-HEART-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; APOLIPOPROTEIN-B; HDL CHOLESTEROL; BLOOD-PRESSURE; STROKE; HYPERTRIGLYCERIDEMIA; POPULATION;
D O I
10.1016/j.atherosclerosis.2009.09.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: The impact of elevated triglycerides (TG) and non-high density lipoprotein cholesterol (non-HDLC) on the incidence of stroke and myocardial infarction (MI) has not been well evaluated in Asian populations such as in Japan, which have a lower incidence of myocardial infarction, but a higher risk of stroke than Western populations. Methods: The authors conducted an 11.7-year prospective study ending in 2005 of 5098 Japanese aged 30-79 living in an urban population, initially free of stroke or MI. The relationship between serum lipids and the risk for stroke and MI was determined by dividing the participants into four groups stratified by the combination of serum levels of TG and non-HDLC. The cut-off value was 1.7 mmol/L for TG and 4.9 mmol/L for non-HDLC. Results and conclusion: The total person-years were 59,774 (27,461 for men and 32,313 for women). During the follow-up period, there were 113 cases of MI and 180 of stoke (with 116 cerebral infarctions). Compared with the low TG/low non-HDLC group, the hazard ratio (95% confidence interval) for MI in the high TG/high non-HDLC group was 2.55 (1.53-4.24) after adjustment for other cardiovascular risk factors. The hazard ratio for cerebral infarction in the high TG alone group was 1.63 (1.03-2.56); however, the risk of cerebral infarction was not significantly increased in the other groups. High serum levels of TG and non-HDLC are both important targets for the prevention of cardiovascular disease in Japan. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:290 / 294
页数:5
相关论文
共 50 条
  • [41] Triglyceride and non-high-density lipoprotein cholesterol as predictors of cardiovascular disease risk factors in Chinese Han children
    Zhu, Wei Fen
    Liang, Li
    Wang, Chun Lin
    Fu, Jun Fen
    INDIAN PEDIATRICS, 2013, 50 (04) : 394 - 398
  • [42] Triglyceride and non-high-density lipoprotein cholesterol as predictors of cardiovascular disease risk factors in Chinese Han children
    Wei Fen Zhu
    Li Liang
    Chun Lin Wang
    Jun Fen Fu
    Indian Pediatrics, 2013, 50 : 394 - 398
  • [43] Temporal decline in non-high-density lipoprotein cholesterol in subjects with diabetes mellitus without atherosclerotic cardiovascular disease
    Vega, Gloria Lena
    Wang, Jijia
    Grundy, Scott M.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2020, 14 (04) : 425 - 430
  • [44] Role of non-high-density lipoprotein cholesterol in prevention of cardiovascular disease: updated evidence from clinical trials
    Xydakis, AM
    Ballantyne, CM
    CURRENT OPINION IN CARDIOLOGY, 2003, 18 (06) : 503 - 509
  • [45] Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial Dysbetalipoproteinemia
    Heidemann, Britt E.
    Koopal, Charlotte
    Lennep, Jeanine E. Roeters van
    Stroes, Erik S.
    Riksen, Niels P.
    Mulder, Monique T.
    van Vark - van der Zee, Leonie C.
    Blackhurst, Dee M.
    Visseren, Frank L. J.
    Marais, A. David
    CLINICA CHIMICA ACTA, 2023, 539 : 114 - 121
  • [46] Optimal Management Target for Non-High-Density Lipoprotein Cholesterol
    Tada, Hayato
    Kobayashi, Junji
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2016, 23 (04) : 399 - 401
  • [47] Non-high-density lipoprotein cholesterol: The forgotten therapeutic target
    Maki, KC
    Galant, R
    Davidson, MH
    AMERICAN JOURNAL OF CARDIOLOGY, 2005, 96 (9A): : 59K - 64K
  • [48] ASSESSING HYPERCHOLESTEROLEMIAS BY TOTAL AND NON-HIGH-DENSITY LIPOPROTEIN CHOLESTEROL
    LIPPI, U
    GRAZIANI, MS
    SCHINELLA, M
    TELLINI, U
    CLINICAL CHEMISTRY, 1990, 36 (07) : 1391 - 1391
  • [49] Utility of non-high-density lipoprotein cholesterol in hemodialyzed patients
    Schreier, L
    González, AI
    Elbert, A
    Berg, G
    Wikinski, R
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (08): : 1013 - 1015
  • [50] Association of non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio with cardiovascular outcomes in patients with type 2 diabetes mellitus: Evidence from the ACCORD cohort
    Liu, Maojun
    Pei, Junyu
    Zeng, Cheng
    Xin, Ying
    Zhang, Yifeng
    Tang, Peiqi
    Deng, Simin
    Hu, Xinqun
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 300 - 311